Literature DB >> 12503704

Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patients.

A Jung1, I Kleinau, G Schönian, A Bauernfeind, C Chen, M Griese, G Döring, U Göbel, U Wahn, K Paul.   

Abstract

A controversy exists concerning the adequate specimen to characterise colonisation of cystic fibrosis (CF) airways by Pseudomonas aeruginosa. Oropharyngeal, sputum and bronchoalveolar lavage samples were evaluated from 38 stable CF patients for the detection of P. aeruginosa, genetically different isolates within the same host and longitudinal variations in the genotype during repeated examinations. Bacterial isolates were typed by pulsed-field gel electrophoresis of deoxyribonucleic acid macrorestriction fragments. Sensitivity, negative and positive predictive values and specificity to detect P. aeruginosa were 35.7, 73.5, 83.3 and 96.2% for oropharyngeal cultures in nonexpectorating patients and 91.7, 94.1, 100 and 100% for sputum cultures from expectorating patients, respectively. Genotypes of Pseudomonas isolates recovered from oropharyngeal swabs and sputum differed to the strains recovered by bronchoscopy in 55% and 40%, respectively. In 62% longitudinal variations in the genotype occurred. One-half of these alterations were detectable by bronchoscopy only. In conclusion, sputum samples were of equal value as specimens from bronchoalveolar lavage to detect Pseudomonas aeruginosa colonisation. Cultures from the oropharynx are not suitable for characterising bacterial conditions in the cystic fibrosis lung. Different genotypes within the same host and longitudinal genetic alterations are common and may be detectable in the bronchoalveolar lavage fluid exclusively.

Entities:  

Mesh:

Year:  2002        PMID: 12503704     DOI: 10.1183/09031936.02.00268002

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

1.  Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections.

Authors:  Christiane Beckmann; Mitchell Brittnacher; Robert Ernst; Nicole Mayer-Hamblett; Samuel I Miller; Jane L Burns
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis.

Authors:  Timothy J Kidd; Keith Grimwood; Kay A Ramsay; Paul B Rainey; Scott C Bell
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

Review 3.  Is bronchoscopy an obsolete tool in cystic fibrosis? The role of bronchoscopy in cystic fibrosis and its clinical use.

Authors:  Lisa Paul
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

4.  Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.

Authors:  Geraint B Rogers; Stuart Skelton; David J Serisier; Christopher J van der Gast; Kenneth D Bruce
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

5.  Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

Authors:  Scott D Sagel; Ronald L Gibson; Julia Emerson; Sharon McNamara; Jane L Burns; Jeffrey S Wagener; Bonnie W Ramsey
Journal:  J Pediatr       Date:  2008-09-25       Impact factor: 4.406

Review 6.  Endpoints for clinical trials in young children with cystic fibrosis.

Authors:  Stephanie D Davis; Alan S Brody; Mary J Emond; Lyndia C Brumback; Margaret Rosenfeld
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

7.  Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis.

Authors:  R Corech; A Rao; A Laxova; J Moss; M J Rock; Z Li; M R Kosorok; M L Splaingard; P M Farrell; J T Barbieri
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 11.677

8.  Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening.

Authors:  D Hayes; P M Farrell; Z Li; S E West
Journal:  Pediatr Pulmonol       Date:  2010-01

9.  A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa.

Authors:  Barry Linnane; Linda Kearse; Nuala H O'Connell; John Fenton; Miranda G Kiernan; Colum P Dunne
Journal:  BMC Pulm Med       Date:  2015-10-06       Impact factor: 3.317

10.  Volatile molecules from bronchoalveolar lavage fluid can 'rule-in' Pseudomonas aeruginosa and 'rule-out' Staphylococcus aureus infections in cystic fibrosis patients.

Authors:  Mavra Nasir; Heather D Bean; Agnieszka Smolinska; Christiaan A Rees; Edith T Zemanick; Jane E Hill
Journal:  Sci Rep       Date:  2018-01-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.